Middle East and Africa Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Software Type (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software); Delivery Mode (On-premise, and Cloud-based); End User (Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), and Business Process Outsourcing (BPO) Firms)

Market Introduction

Pharmacovigilance (PV) plays an essential role in the healthcare system through assessment, monitoring, and finding of drug interactions and their effects in human. Pharmacovigilance helps companies to monitor any adverse drug reaction events during the trial phase and also during the post marketing period.

Thus, the globalization of pharmacovigilance are expected to create a significant demand for pharmacovigilance and drug safety software in the coming years, which is further anticipated to drive the pharmacovigilance and drug safety software market.

The Pharmacovigilance and Drug Safety Software market in this pandemic is on increasing due to the increased demand for treatments due to the outbreak of COVID-19. There is a current focus on drug safety in this area and how one can avoid counterfeit drugs from entering the supply chain. Methods for regional cooperation and expertise gained from more active projects should be improved. Technology must be used to improve the ability to report spontaneously and to make data available for processing. The countries mainly focused on the treatment of COVID-19 19 patients and hence the Pharmacovigilance and Drug Safety Software is facing impact. Based on the above-mentioned reason, the market of the Pharmacovigilance and Drug Safety Software is likely to impact.

Get more information on this report :

Market Overview and Dynamics

The pharmacovigilance and drug safety software market in Middle East and Africa is expected to grow from US$ 6.1 million in 2019 to US$ 9.9 million by 2027; it is estimated to grow at a CAGR of 6.0% from 2020 to 2027. Pharmacovigilance is the processes for monitoring and evaluating adverse drug reactions and it is a key component of effective drug regulation systems, clinical practice and public health programs. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled. In the current network of pharmacovigilance centers coordinated by the Uppsala Monitoring Centre, pharmacovigilance is a critical and integral part of clinical research and these days it is growing in many countries. Today many pharmacovigilance centers are working for drug safety monitoring, however, at the turn of the millennium pharmacovigilance faces major challenges in aspect of better safety and monitoring of drugs. Thus, increasing the globalization in pharmacovigilance sector helps in drug safety software. It improves the quality and efficacy of pharmacovigilance and drug safety software and is expected to favor the growth of the market during the forecast period.

Key Market Segments

In terms of software type, the adverse event reporting software segment accounted for the largest share of the Middle East and Africa pharmacovigilance and drug safety software market in 2019. In terms of delivery mode, the on-premise segment held a larger market share of the pharmacovigilance and drug safety software market in 2019. In terms of end user, the contract research organizations segment held a larger market share of the pharmacovigilance and drug safety software market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Pharmacovigilance and drug safety software market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Veeva Systems, IQVIA Inc., ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, and EXTEDO.

Reasons to buy report

To understand the Middle East and Africa pharmacovigilance and drug safety software market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa pharmacovigilance and drug safety software market
Efficiently plan M&A and partnership deals in Middle East and Africa pharmacovigilance and drug safety software market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa pharmacovigilance and drug safety software market
Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East and Africa region.

MIDDLE EAST AND AFRICA PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SEGMENTATION

By Software Type

Fully Integrated Software
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software

By Delivery Mode

Cloud-based
On-premise

By End User

Contract Research Organizations
Pharmaceutical and Biotech Companies
Business Process Outsourcing

By Country

Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa

Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Pharmacovigilance and Drug Safety Software Market – By Software Type

1.3.2 Pharmacovigilance and Drug Safety Software Market – By Delivery Mode

1.3.3 Pharmacovigilance and Drug Safety Software Market – By End User

1.3.4 Middle East and Africa Pharmacovigilance and Drug Safety Software Market – By Country

2. Middle East and Africa Pharmacovigilance and Drug Safety Software Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East and Africa Pharmacovigilance and Drug Safety Software Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Pharmacovigilance and Drug Safety Software Market- Middle East and Africa PEST Analysis

4.3 Expert Opinion

5. Middle East and Africa Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Adverse Drug Reactions (ADRs)

5.1.2 Globalization of Pharmacovigilance

5.2 Market Restraints

5.2.1 Expensive Technology

5.3 Market Opportunities

5.3.1 Growth Opportunities in Developing Countries

5.4 Future Trends

5.4.1 Artificial Intelligence in Pharmacovigilance

5.5 Impact Analysis

6. Pharmacovigilance and Drug Safety Software Market – Middle East and Africa Analysis

6.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue Forecasts and Analysis

7. Middle East and Africa Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Software Type

7.1 Overview

7.2 Pharmacovigilance and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

7.3 Adverse Event Reporting Software Market

7.3.1 Overview

7.3.2 Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Drug Safety Audits Software

7.4.1 Overview

7.4.2 Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Issue Tracking Software

7.5.1 Overview

7.5.2 Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Fully Integrated Software

7.6.1 Overview

7.6.2 Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8. Middle East and Africa Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Delivery Mode

8.1 Overview

8.2 Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)

8.3 On-premise

8.3.1 Overview

8.3.2 On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Cloud- Based

8.4.1 Overview

8.4.2 Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9. Middle East and Africa Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts to 2027– By End User

9.1 Overview

9.2 Pharmacovigilance (PV) and Drug Safety Software Market, By End User, 2019 & 2027 (%)

9.3 Pharmaceutical and Biotech Companies Market

9.3.1 Overview

9.3.2 Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Contract Research Organizations (CROs) Market

9.4.1 Overview

9.4.2 Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Business Process Outsourcing (BPO) Firms Market

9.5.1 Overview

9.5.2 Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10. Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1 Middle East & Africa: Pharmacovigilance and Drug Safety Software Market

10.1.1 Overview

10.1.2 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.1.3 UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.1 UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.2 UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.3.3 UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.3.4 UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.4 Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.1 Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.2 Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.4.3 Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.4.4 Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.5 South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.1 South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.2 South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.5.3 South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.5.4 South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.6 Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1 Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2 Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.6.3 Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.6.4 Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Middle East and Africa Pharmacovigilance and Drug Safety Software Market

11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

12.3 Organic Developments

12.3.1 Overview

12.3.2 Organic Developments Done by Companies

12.4 Inorganic Developments

12.4.1 Overview

12.4.2 Inorganic Growth Strategies by Companies

13. COMPANY PROFILES

13.1 Veeva Systems

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 IQVIA Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 ArisGlobal LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sparta Systems

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Oracle Corporation

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Sarjen Systems Pvt. Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 EXTEDO

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 2. UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 3. UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 4. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 5. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 6. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 7. South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 8. South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 9. South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 10. Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 11. Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 12. Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 13. Organic Developments Done by Companies

Table 14. Recent Inorganic Growth Strategies by the Companies

Table 15. Glossary of Terms, Pharmacovigilance and Drug Safety Software Market

LIST OF FIGURES

Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation

Figure 2. Middle East and Africa Pharmacovigilance and Drug Safety Software Market Overview

Figure 3. Adverse Event Reporting Software Segment Held Largest Share of Software Type in Pharmacovigilance and Drug Safety Software Market

Figure 4. Contract Research Organizations Segment Held Largest Share of End User in Pharmacovigilance and Drug Safety Software Market

Figure 5. UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Pharmacovigilance and Drug Safety Software Market - Middle East and Africa PEST Analysis

Figure 7. Pharmacovigilance and Drug Safety Software Market Impact Analysis of Driver and Restraints

Figure 8. Middle East and Africa Pharmacovigilance and Drug Safety Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Pharmacovigilance and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

Figure 10. Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)

Figure 15. On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. Pharmacovigilance (PV) and Drug Safety Software Market, by End User, 2019 & 2027 (%)

Figure 18. Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue Overview, By Country, 2019 (US$ Mn)

Figure 22. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 23. UAE Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. South Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 28. Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa pharmacovigilance and drug safety software market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa pharmacovigilance and drug safety software market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the pharmacovigilance and drug safety software market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample